Anesthesia, Perioperative Care, and Sedation

Published on 25/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2373 times

Chapter 70 Anesthesia, Perioperative Care, and Sedation

The primary purpose of general anesthesia is to suppress the conscious perception of, and physiologic response to, noxious stimuli and to render the patient unconscious. Potent drugs are used to blunt physiologic responses to what would otherwise be life-threatening trauma (surgery). Intraoperatively, the anesthesiologist is responsible for providing analgesia as well as physiologic and metabolic stability (see Table 70-1 on the Nelson Textbook of Pediatrics website at image www.expertconsult.com). This responsibility is facilitated by obtaining an adequate preanesthesia history (see Table 70-2 on the Nelson Textbook of Pediatrics website at image www.expertconsult.com). The increased risk of morbidity and mortality in the perioperative period demands the utmost vigilance. The risk is even higher in certain disease states (see Table 70-3 on the Nelson Textbook of Pediatrics website at image www.expertconsult.com).

Table 70-2 THE PREANESTHETIC HISTORY

Child’s previous anesthetic and surgical procedures:

Perinatal problems (especially for infants):

Other major illnesses and hospitalizations

Family history of anesthetic complications, malignant hyperthermia, or pseudocholinesterase deficiency

Respiratory problems:

Cardiac problems:

Gastrointestinal problems:

Exposure to exanthems or potentially infectious pathogens

Neurologic problems:

Hematologic problems:

Renal problems:

Psychosocial considerations:

Gynecologic considerations:

Current medications:

Allergies:

Dental condition (loose or cracked teeth)

When and what the child last ate (especially in emergency procedures)

Table 70-3 SPECIFIC PEDIATRIC DISEASES AND THEIR ANESTHETIC IMPLICATIONS

DISEASE IMPLICATIONS
RESPIRATORY SYSTEM
Asthma Intraoperative bronchospasm that may be severe
Pneumothorax or atelectasis
Optimal preoperative medical management is essential; preoperative steroids may be required
Difficult airway Special equipment and personnel may be required
Should be anticipated in children with dysmorphic features or acute airway obstruction, as in epiglottitis or laryngotracheobronchitis or with an airway foreign body
Patients with Down syndrome may require evaluation of the atlanto-occipital joint
Patients with storage diseases may be at high risk
Bronchopulmonary dysplasia Barotrauma with positive pressure ventilation
Oxygen toxicity, pneumothorax a risk
Cystic fibrosis Airway reactivity, bronchorrhea
Risk of pneumothorax, pulmonary hemorrhage
Atelectasis
Patient should be assessed for cor pulmonale
Sleep apnea Pulmonary hypertension and cor pulmonale must be excluded
Careful postoperative observation for obstruction required
CARDIAC
  Need for antibiotic prophylaxis for bacterial endocarditis
Use of air filters; careful purging of air from the intravenous equipment
Physician must understand the effects of various anesthetics on the hemodynamics of specific lesions
Preload optimization and avoidance of hyperviscous states in cyanotic patients
Possible need for preoperative evaluation of myocardial function and pulmonary vascular resistance
Provide information about pacemaker function and ventricular device function
HEMATOLOGIC
Sickle cell disease Possible need for simple or exchange transfusion based on preoperative hemoglobin concentration and percentage of hemoglobin S
Importance of avoiding acidosis, hypoxemia, hypothermia, dehydration, and hyperviscosity states
Oncology Pulmonary evaluation of patients who have received bleomycin, bis-chloroethyl-nitrosourea, chloroethyl-cyclohexyl-nitrosourea, methotrexate, or radiation to the chest
Avoidance of high oxygen concentration
Cardiac evaluation of patients who have received anthracyclines; risk of severe myocardial depression with volatile agents
Potential for coagulopathy
RHEUMATOLOGIC
  Limited mobility of the temporomandibular joint, cervical spine, arytenoid cartilages
Careful preoperative evaluation required
Possible difficult airway
GASTROINTESTINAL
Esophageal, gastric Potential for reflux and aspiration
Liver High overall morbidity and mortality in patients with hepatic dysfunction
Altered metabolism of some drugs
Potential for coagulopathy
Renal
  Altered electrolyte and acid-base status
Altered clearance of some drugs
Need for preoperative dialysis in selected cases
Succinylcholine to be used with extreme caution and only when the serum potassium level has recently been shown to be normal
NEUROLOGIC
Seizure disorder Avoidance of anesthetics that may lower the threshold
Optimal control ascertained preoperatively
Preoperative serum anticonvulsant measurements
Increased intracranial pressure Avoidance of agents that increase cerebral blood flow
Avoidance of hypercarbia
Neuromuscular disease Avoidance of depolarizing relaxants; at risk for hyperkalemia
Patient may be at risk for malignant hyperthermia
Developmental delay Patient may be uncooperative at induction
Psychiatric Monoamine oxidase inhibitor (or cocaine) may interact with meperidine, resulting in hyperthermia and seizures
Selective serotonin reuptake inhibitors may induce or inhibit various hepatic enzymes that may alter anesthetic drug clearance
Illicit drugs may have adverse effects on cardiorespiratory homeostasis and may potentiate the action of anesthetics
ENDOCRINE
Diabetes Greatest risk is unrecognized intraoperative hypoglycemia; if insulin is administered, intraoperative blood glucose level monitoring needed ; glucose and insulin must be provided, with adjustment for fasting condition and surgical stress
SKIN
Burns Difficult airway
Risk of rhabdomyolysis and hyperkalemia from succinylcholine
Fluid shifts
Bleeding
Coagulopathy
IMMUNOLOGIC
  Retroviral drugs may inhibit benzodiazepine clearance
Immunodeficiency requires careful infection control practices
Cytomegalovirus-negative blood products, irradiation, or leukofiltration may be required
METABOLIC
  Careful assessment of glucose homeostasis in infants

General Anesthesia

Analgesia

Providing analgesia for procedures both in and out of the operating room is a major responsibility and functions within a spectrum of care (Table 70-4). Techniques exist to provide profound pain relief during operative procedures for all patients, including the most critically ill infants. Blunting the physiologic responses to painful stimuli inhibits the stress response and its multiple deleterious physiologic and metabolic consequences. The response to painful and stressful stimuli is a potent stimulus of the systemic inflammatory response syndrome (SIRS), which leads to increased catabolism, physiologic instability, and increased mortality (Chapter 64). Appropriate use of medication, such as fentanyl anesthesia in neonates, reduces the incidence of postoperative bradycardia, hypotension, acidosis, interventricular hemorrhage, coagulation abnormalities, hypoglycemia, and death.

Table 70-4 DEFINITIONS OF ANESTHESIA CARE

MONITORED ANESTHESIA CARE

LIGHT SEDATION

Administration of anxiolysis and/or analgesia that obtunds consciousness but does not obtund normal protective reflexes (cough, gag, swallow, hemodynamic reflexes).

DEEP SEDATION

Sedation that obtunds consciousness and normal protective reflexes or possesses a significant risk of blunting normal protective reflexes (cough, gag, swallow, hemodynamic reflexes).

GENERAL ANESTHESIA

Administration of hypnosis, sedation, and analgesia that results in the loss of normal protective reflexes.

REGIONAL ANESTHESIA

LOCAL ANESTHESIA

NO ANESTHESIOLOGIST

An anesthesiologist will not be involved in the care of the child in any way.

Hypnosis and Amnesia

The blunting of both consciousness (hypnosis) and conscious recall (amnesia) is a crucial feature of pediatric anesthesia care. Awareness of painful, anxiety-provoking, and stressful conditions for children is just as deleterious, physically and psychologically, as the painful procedures themselves. Management is aimed at blunting the fear and emotional response during surgery, painful procedures (bone marrow aspiration, lumbar punctures), or nonpainful but anxiety-provoking procedures (MRI, CT). Many drugs provide anxiolysis, blunting of recall, and amnesia for such events (Table 70-5). Obtundation of consciousness may accompany the provision of analgesia. Hypnotic and sedative agents can induce altered consciousness without producing any analgesia; analgesia and obtunded consciousness are not synonymous. It is also possible to provide analgesia (local, spinal, or epidural analgesia) without obtunding consciousness.

Table 70-5 SELECTED DRUGS USED IN ANESTHESIA

DRUG USES AND IMPLICATIONS
MUSCLE RELAXANTS
Succinylcholine Used to facilitate endotracheal intubation and maintain muscle relaxation in emergency situations; now virtually never given routinely
A depolarizing neuromuscular blocking agent with rapid onset and offset properties
Associated with the development of malignant hyperthermia in susceptible patients
Degraded by plasma cholinesterase, which may be deficient in some individuals; such a deficiency may result in prolonged effect
Fasciculations may be associated with immediate increases in intracranial and intraocular pressures as well as postoperative muscle pain
Pancuronium, vecuronium, cis-atracurium, D-tubocurarine (curare) Nondepolarizing neuromuscular blockers
Have less rapid onset than succinylcholine butare longer-acting
Pancuronium is vagolytic, so may be of benefit in newborns, who have high levels of vagal tone; rarely used
Vecuronium and rocuronium are metabolized by the liver and excreted in bile; the most commonly used
Cis-atracurium is metabolized by plasma cholinesterase and therefore may be of benefit in patients with hepatic or renal disease
Curare releases histamine and is long-acting
HYPNOTICS
Propofol Rapidly acting hypnotic; amnestic, but not analgesic
Like pentothal, may cause hypotension
Causes respiratory depression
May increase the seizure threshold
Great utility in titrated doses for sedation and with local anesthetic and short-acting opioid for outpatient procedures
May suppress nausea
Associated with the often fatal propofol infusion syndrome when used in prolonged intravenous infusion (>24 hr) and therefore not used for ICU sedation in children
Etomidat Cardiovascular stability on induction with no increase in intracranial pressure
Inhibits corticosteroid synthesis and increases ICU mortality
Associated with myoclonus, potential difficulty with assisted ventilation, and pain on injection
Ketamine Hypnotic analgesic and amnestic
Causes sialorrhea and should be coadministered with an antisialagogue, such as atropine or glycopyrrolate
May be associated with laryngospasm
Causes endogenous catecholamine release, tachycardia, and bronchodilation
Increases intracranial and intraocular pressures
Decreases the seizure threshold
Thiopental Used to induce a state of unconsciousness; rarely used
Rapidly acting hypnotic, but not an analgesic
Offset is by redistribution, not by metabolism
May cause hypotension because of its myocardial depressant effects and by vasodilation
Causes respiratory depression
Releases histamine and may be associated with bronchospasm in susceptible individuals
Increases the seizure threshold
SEDATIVE-ANXIOLYTICS
Benzodiazepines May produce sedation, anxiolysis, or hypnosis, depending on the dose
May produce antegrade but not retrograde amnesia
All agents raise the seizure threshold, are metabolized by the liver, and depress respiration, especially when administered with opioids
Frequently administered as premedications
Diazepam may be painful on injection and has active metabolites
Midazolam can be administered by various routes and has a short half-life
Lorazepam has no active metabolites
Sedation effected by all benzodiazepines may be reversed by flumazenil, but respiratory depression may not be reliably reversed
Dexmedetomidine Produces anxiolysis, sedation, sympatholysis, by α2-receptor stimulation centrally; has mild analgesic properties
Side effects include hypotension and bradycardia
Increasingly used for procedural sedation
Continuous infusion for ICU sedation; currently limited to 24 hr
ANALGESIC-SEDATIVES
Opioids Gold standard for providing analgesia
May cause respiratory depression
Morphine and, to a lesser extent, hydromorphone may cause histamine release
The synthetic opioids fentanyl, sufentanil, and short-acting alfentanil may have a greater propensity to cause chest wall rigidity when administered rapidly or in high doses and are also associated with the rapid development of tolerance; these 3 drugs have particular utility in cardiac surgery because of the hemodynamic stability associated with their use
Remifentanil is an ultra–short-acting synthetic opioid that is metabolized by plasma cholinesterase; it may have particular utility when deep sedation and analgesia are required along with the ability to assess neurologic status intermittently
INHALATIONAL AGENTS
Nitrous oxide Causes amnesia and mild analgesia at low concentrations
Danger of hypoxic mixture if the oxygen concentration is not monitored and preventive safety mechanisms are not in place
Potent vapors “Complete anesthetics”—they induce a state of hypnosis, analgesia, and amnesia
All are myocardial depressants, and some are vasodilators
May trigger malignant hyperthermia in susceptible individuals
Isoflurane and enflurane are fluorinated ethers and isomers
Enflurane may lower the seizure threshold—rarely used
Halothane has been the gold standard for performing inhalation induction of anesthesia in children, but sevoflurane, a newer drug, is also well tolerated and has more rapid kinetics (onset and offset) because of its low solubility in blood. No longer available in the USA.
Sevoflurane is almost universally used for inhalation induction of anesthesia in children.
All are bronchodilators at equipotent concentrations
Isoflurane, enflurane, and especially desflurane are associated with a higher incidence of laryngospasm, when used for anesthetic induction, than sevoflurane

ICU, intensive care unit.

Sedation describes a medically induced state that is on a continuum between the fully alert, awakened state and general anesthesia (see Table 70-4). In addition to inducing unconsciousness and amnesia, general anesthesia obtunds or ablates critical physiologic reflexes; the most important are airway-protective reflexes: coughing, gagging, and swallowing. Cardiorespiratory reflexes are also obtunded with general anesthesia; respiratory depression and hemodynamic compromise may occur and may be profound. As sedation deepens toward general anesthesia, loss of airway patency, loss of airway-protective reflexes, and loss of cardiovascular stability occur. Light (minimal) sedation is anxiolysis without loss of these reflexes or airway patency. Deep sedation occurs when these reflexes are obtunded or lost (see Table 70-4). Adequate sedation in children may be accompanied by the actual or potential loss of vital reflexes. It is mandatory that those providing sedation for a child be able to detect the transition into deep sedation and general anesthesia and be prepared to manage the child’s airway and circulation, and provide cardiopulmonary resuscitation (CPR) if required.

Akinesia (Immobility or Muscular Relaxation)

Akinesia is the absence of movement. It is necessary to ensure safe and adequate operative conditions and to provide ideal conditions for advanced and meticulous surgery. Akinesia is produced with muscle relaxants (see Table 70-5). These agents facilitate respiratory management in the perioperative period and in critically ill patients. The absence of movement is neither the absence of pain nor the presence of amnesia. Whenever neuromuscular blocking agents are used, analgesia and sedation must be provided.

Physiologic Support

The need for anesthesia increases the need to monitor and support physiologic integrity and homeostasis. Sedation and anesthesia have significant and potentially life-threatening physiologic consequences (see Tables 70-4 and 70-5). Maintenance of adequate cardiorespiratory function, fluid management, electrolyte control, thermoregulation, and concern for all aspects of the child’s health are critical during anesthesia.

Induction of General Anesthesia

The goal of induction of general anesthesia is to rapidly achieve surgical anesthesia by using intravenous (IV) or, more commonly in children, inhalational induction agents. In children who are too young to tolerate the establishment of vascular access before the induction of anesthesia, it is routine to induce anesthesia by mask inhalation of volatile anesthetics. In the operating room, a child is often accompanied by the parents (parental presence during induction [PPI]) and placed on the operating room table. Before the induction of anesthesia, monitors are usually applied to the child. These include a pulse oximeter, electrocardiogram (ECG) electrodes, and, frequently, a blood pressure cuff. The child is then cautiously introduced to the face mask, which contains a high gas flow (5-7 L/min of oxygen), frequently mixed with nitrous oxide (N2O). Inhalation of nitrous oxide and oxygen for 60-90 sec induces a state of euphoria. The airway responses to inhalational anesthetics are now blunted, and sevoflurane can be introduced into the inhaled gas mixture. This leads to unconsciousness within 30-60 sec while the child continues to breathe spontaneously.

The child is now “asleep,” and the parents can be asked to leave. An IV line is then started, and comprehensive intraoperative monitoring initiated. Surgical anesthesia can be maintained by spontaneous ventilation with a mask; this is safe only when the airway is secure and patent, the stomach is empty, and the child is >6 mo of age. Procedures >1 hr are not usually performed with mask inhalational anesthesia. If these conditions are not met, if the surgeon needs to approach the airway, or if muscular paralysis is required, then the airway must be secured with endotracheal intubation. Although endotracheal intubation can be performed under deep inhalational anesthesia with respiratory depression and obtunded cough and gag reflexes, the depth of anesthesia required to ablate airway reflexes is very close to the level that induces hemodynamic instability. After anesthetic induction, IV access is secured and anesthesia is deepened with IV agents. Muscle relaxation with IV, nondepolarizing muscle relaxants is induced to facilitate endotracheal intubation. Succinylcholine is rarely if ever used. After paralysis is induced, direct laryngoscopy and airway intubation can be performed. Correct endotracheal tube placement is confirmed by direct laryngoscopy, end-tidal CO2 measurement, endotracheal tube fogging, and the finding of bilaterally equal breath sounds during positive pressure ventilation. If necessary, fiberoptic airway endoscopy and chest radiograph, in addition to these measures, can be used to confirm correct endotracheal tube placement.

After endotracheal intubation, spontaneous ventilation may be permitted, if muscle relaxants are not used or have worn off; it is routine to provide controlled mechanical ventilation. When the child is completely anesthetized, positioned for surgery, and hemodynamically stable, and maintenance anesthesia is achieved, the surgery can begin.

Inhalational Anesthetics

General anesthesia may be induced and maintained by either inhalation or the IV route. The inhalational anesthetics used in children include sevoflurane, isoflurane, and desflurane. Although halothane is the prototypical pediatric inhalational anesthetic agent, it is no longer used in the USA.

The minimal alveolar concentration (MAC) of an inhalational anesthetic is the alveolar concentration (expressed as percent at 1 atmosphere) that provides sufficient depth of anesthesia for surgery in 50% of patients. For potent inhalational agents, the alveolar concentration of an anesthetic reflects the arterial concentration of anesthetic in the blood perfusing the brain. Thus, the MAC is an indication of anesthetic potency and is analogous to the ED50 (effective dose in 50% of recipients) of a drug. MAC is age-dependent, is lower in premature infants than in full-term infants, and decreases from term through infancy to preadolescence. In adolescence, MAC again increases, falling thereafter. Inhalational anesthetic agents are poorly soluble in blood but rapidly equilibrate between alveolar gas and blood. The less soluble an anesthetic agent is in blood (low blood gas partition coefficient, or ratio of the anesthetic concentration in the blood to the alveolar gas at equilibrium), the more rapid are both the induction of and the emergence from inhalational anesthesia with that agent. Blood gas partition coefficients for sevoflurane (0.69) and desflurane (0.42) are lower than that for halothane (2.4).

Specific Anesthetics

Nitrous Oxide

Nitrous oxide is a tasteless, colorless, odorless gas with potent analgesic properties. It induces a state of euphoria (hence its nickname, “laughing gas”). The MAC of nitrous oxide is >100; therefore, it is not suitable as a sole agent to maintain anesthesia. Nevertheless, nitrous oxide has few complications and produces little or no hemodynamic or respiratory depression. Commonly, during maintenance of general anesthesia, the inhalational gas mixture is 70% nitrous oxide and 30% oxygen, with the addition of an inhalational anesthetic or potentiation of analgesia with an opioid or a hypnotic agent. Nitrous oxide has a remarkably low blood gas partition coefficient (0.47), so it rapidly reaches alveolar equilibrium. Induction with and emergence from nitrous oxide–induced anesthesia is quite rapid. The deleterious effects of nitrous oxide are increased postoperative nausea and vomiting and, with long-term use (days), bone marrow suppression. Although there is no evidence of harmful sequelae of the use of nitrous oxide for routine pediatric anesthesia, its use has decreased because of the greater incidence of nausea and vomiting associated with it. Nitrous oxide is a potent analgesic that is safely used in a mixture of 50% nitrous oxide and oxygen (Entonox) in obstetrics and in emergency departments to provide analgesia. Although this combination appears to be safe, it potentiates the respiratory depressive effects of opioids, and its use, in combination with any other sedative, hypnotic, or opioid agent, requires very close monitoring because it may produce general anesthesia.

Intravenous Anesthetic Agents

Anesthesia can be both induced and maintained with either intermittent boluses or continuous infusions of IV anesthetic agents. Intravenous anesthetics include barbiturates, opioids, benzodiazepines, and miscellaneous drugs, such as propofol and ketamine. Intravenous anesthetic agents can induce anesthesia more rapidly than inhalational anesthetics, with fewer complications. Vascular access is required, so unless IV access has already been obtained, inhalation induction is the preferred route. For children arriving in the operating room with vascular access, IV induction should be routine, because it rapidly takes the child from the awake state to the anesthetized state with less psychologic and cardiorespiratory compromise than occurs with inhalational induction. All IV agents affect cardiorespiratory function. The one exception to this may be ketamine, which, in lower doses, releases catecholamines, which maintain cardiac function and blood pressure.

Ketamine

Ketamine rapidly induces general anesthesia that lasts for 15-30 min when given at 1-3 mg/kg IV. It has few side effects and can maintain adequate blood pressure and cardiac output. Ketamine is also effective when given intramuscularly, subcutaneously, nasally, or orally; the dose must be increased for these alternative routes. Ketamine dissociates the connections between the cortex and limbic system (dissociative anesthesia) by its inhibition of N-methyl-D-aspartate (NMDA) receptors, producing a unique anesthetic state. Ketamine is not only a hypnotic agent, providing obtundation and loss of consciousness, but also an analgesic agent, and can act as a sole IV agent to provide general anesthesia. With low doses of this agent, airway reflexes and spontaneous ventilation may be maintained; at higher doses, loss of airway reflexes, apnea, and respiratory depression occur. It is unwise to rely on ketamine to prevent aspiration of gastric contents during deep sedation. Intravenous ketamine is a useful general anesthetic agent for short procedures.

Ketamine produces disturbing postanesthetic dreams and hallucinations. These can occur at the time of emergence from anesthesia and for several weeks. In adults, the incidence of this effect is 30-50%. In prepubertal children, it may be 5-10%. Premedication with a benzodiazepine, such as midazolam, greatly reduces these sequelae; a benzodiazepine is routinely added in children receiving ketamine anesthesia. The other side effect of ketamine is that it is a potent secretagogue, enhancing oral and bronchial secretions. A drying agent, such as atropine or glycopyrrolate, is administered before the administration of ketamine.

A bronchial smooth muscle relaxant (bronchodilator), ketamine is a useful agent for sedating asthmatic patients and others in the ICU. Ketamine has been reported to increase intracranial pressure and therefore is not indicated in patients at risk for elevated intracranial pressure. Ketamine can increase myocardial oxygen demand and should be used cautiously in patients with impaired myocardial oxygen delivery or cardiac outflow tract obstruction.

Opioids

Opioids are superb analgesic agents, providing analgesia for painful procedures and postprocedural pain (Chapter 71). Large doses of morphine (0.5-2 mg/kg), combined with nitrous oxide, provide adequate analgesia for painful procedures and surgery. Opioids suppress the CO2 response, can induce apnea, and are respiratory depressants. Morphine is often associated with hypotension and bronchospasm from histamine release; it is used with caution in children with asthma. Morphine is a long-acting agent, and an equivalent dose per kilogram gives much higher blood levels in neonates than in older children, with plasma concentrations approximating 3 times those in adults. This reason for this difference is the longer elimination half-life (14 hr) in children than in adults (2 hr). Because of the prolonged activity and hemodynamic instability induced by morphine, the fentanyl class of synthetic opioids has replaced it.

Fentanyl is an effective agent to provide pain relief, analgesia, and sedation for painful procedures, with a shorter duration of action and a more stable hemodynamic profile than morphine. In equal analgesic doses, all opioids are equally potent respiratory depressants. Other anesthetic agents potentiate this respiratory depression, whether they are inhalational anesthetics or IV barbiturates or benzodiazepines.

Fentanyl use at 30-50 µg/kg causes absence of abnormal hemodynamic response to surgery and provides stable operating conditions. Effective analgesia and anesthesia can be provided with IV fentanyl in a 2-3 µg/kg bolus followed by a 1-3 µg/kg/hr continuous infusion. Hemodynamic effects can be blunted and recall totally obtunded with use of a nitrous-narcotic anesthetic technique, although muscle tone may remain high and spontaneous movements can occur. Nitrous-narcotic anesthetics usually are supplemented with a nondepolarizing muscle relaxant during maintenance anesthesia. If the patient will be extubated and resume spontaneous ventilation, reversal of the muscle relaxant is necessary.

Other synthetic opioids (sufentanil, alfentanil, remifentanil) are available, but fentanyl is the most commonly used opioid. Both sufentanil and alfentanil have been used for cardiac anesthesia; their potency is different from that of fentanyl. Alfentanil appears to cause an increased incidence of muscle rigidity, convulsions, and prolonged respiratory depression compared with fentanyl, and is not used in children.

Remifentanil has very rapid onset and offset of action. In doses of 0.25 µg/kg/min, surgical anesthesia can be maintained with this agent. Its short half-life and rapid offset are advantageous for rapid emergence from anesthesia. Unfortunately, its rapid offset of action also leads to postprocedural and postoperative pain and requires analgesic supplementation, frequently with an opioid, which removes the advantage of anesthesia with a short-acting opioid. Remifentanil may have a role in providing rapidly deepening anesthesia for particularly painful events or rapidly inducing analgesia. It is also used intra-operatively by continuous infusion to maintain anesthesia. It is a potent respiratory depressant and provides no postprocedural analgesia, features that limit its use.

Benzodiazepines

Benzodiazepines induce hypnosis, anxiolysis, sedation, and amnesia, and have anticonvulsant activity. In larger doses, they cause respiratory depression and apnea; they are synergistic with opioids and barbiturates in their respiratory depressant effects. Benzodiazepines are gamma-aminobutyric acid (GABA) agonists.

The most commonly used benzodiazepine in pediatric anesthesia is midazolam. Short-acting and water-soluble, it can be injected intravenously without pain. It is a potent hypnotic-anxiolytic-anticonvulsant and is approximately 4 times more potent than diazepam. In anxiolytic doses, midazolam (0.15 mg/kg) has no effect on respiratory rate, heart rate, or blood pressure and provides excellent preoperative sedation that is frequently accompanied by amnesia. It can be administered orally, nasally, rectally, intravenously, or intramuscularly. Use of oral midazolam at a dose of 0.5-1.0 mg/kg, mixed in sweet flavored syrup, induces anxiolysis in approximately 90% of children. This agent has no hemodynamic, oxygenation, or respiratory depressant effects at this dose level, but when midazolam is used as a sole agent, children may frequently lose their balance and head control, may have blurred vision, and rarely may become dysphoric. A child sedated with midazolam should not be left unattended and is not safe walking. Most children rapidly accept an inhalational anesthetic mask after oral midazolam premedication. The widespread use of preoperative oral midazolam has decreased the practice of PPI to calm younger children.

Complications during Induction of Anesthesia

The period between full wakefulness, with the child in control of airway reflexes, and general anesthesia, with total loss of control, is fraught with difficulty. During induction, laryngospasm, bronchospasm, vomiting, pulmonary aspiration of gastric contents, and subsequent aspiration pneumonitis pose a constant threat although they rarely occur. Concern about vomiting and aspiration dictates the use of preanesthetic fasting (NPO) guidelines and indicates rapid sequence anesthetic induction.

Laryngospasm is the most common complication. During induction of anesthesia, especially with inhalational anesthetics, a period of excitement may occur. This period is associated with heightened airway reflexes, which can lead to coughing, gagging, laryngospasm, and bronchospasm. Laryngospasm is reflex closure of the larynx, which makes it impossible for the child to breathe or for ventilation to be used. The child may make violent inspiratory efforts against a closed glottis, generating significantly negative intrathoracic pressure. This may affect cardiovascular function and cause postobstructive pulmonary edema. Laryngospasm can be prolonged, and hypoxia may ensue. Laryngospasm occurs in up to 2% of all anesthetic inductions in children younger than 9 yr and is half as common in older patients. Laryngospasm occurs twice as frequently in children with active or recent upper respiratory tract infection (URI). A history of passive smoking from environmental (parental) tobacco smoke increases the likelihood of laryngospasm 10-fold, and even more if the smoker is the child’s mother.

Laryngospasm can be relieved during induction of anesthesia by increasing the anesthetic dosage, either intravenously or through inhalation (although with the glottis closed, further administration of inhalational anesthesia is not possible). Muscle relaxation relieves laryngospasm, and in an acute situation, this situation may be an indication for succinylcholine. Constant positive airway pressure administered by someone skilled in airway management to ensure patency of the soft tissues of the oropharynx may be beneficial in alleviating laryngospasm. Laryngospasm may also occur during emergence from anesthesia, because a state of excitement is again traversed between deep anesthesia and wakefulness.

Bronchospasm can occur during induction, either in response to histamine release as a result of many of the anesthetic agents or as part of a hyperexcitable stage. Endotracheal intubation may also induce bronchospasm during induction. Bronchospasm during induction is particularly common in children with asthma. Bronchospasm secondary to intubation in a patient with reactive airway disease can be severe, may be associated with life-threatening hypoxemia, and may make it impossible to ventilate the child. The use of histamine-releasing anesthetic agents has been associated with total airway obstruction, respiratory failure, and cardiac arrest. Environmental tobacco smoke is a risk factor.

Other pulmonary problems with induction of anesthesia include massive atelectasis with hypoxemia, impaired ventilation and perfusion, blunted hypoxic pulmonary vasoconstriction, and increased airway secretions with decreased bronchociliary function. Hypersecretion is prevented by the routine use of antisialagogues, such as atropine. The newer inhalation agents are less potent secretagogues, and the use of atropine premedication is much less common, but is probably indicated if ketamine is used.

Hemodynamic complications upon anesthesia induction include hypotension, which can be profound in hypovolemic patients; decreased myocardial function, which can be severe in patients with compromised cardiac function; and tachycardia and cardiac dysrhythmias. Inhalational anesthetics sensitize the myocardium to circulating catecholamines, and induction and excitement are associated with a hypercatecholaminergic state.

Maintenance of Anesthesia

Maintenance of anesthesia is the period between induction and emergence. The child should be asleep, unaware of pain, unresponsive with either motion or hemodynamic responses to painful stimuli, and homeostatically supported. The child is comatose, without airway-protective reflexes and with suppression or absence of respiration, and has received drugs that suppress hemodynamic adaptive responses. The child is also exposed to surgical trauma, and there may be blood loss and significant fluid shifts (third spacing), decreased intravascular volume, and hypothermia.

Anesthesia is usually maintained with or without nitrous oxide, an inhalational anesthetic such as isoflurane or sevoflurane, and an opioid for intraoperative analgesia, potentiation and deepening of anesthesia, and postoperative analgesia. A benzodiazepine is added either during premedication or intraoperatively to supplement hypnosis and amnesia. A nondepolarizing muscle relaxant (vecuronium or rocuronium) completes the pharmacologic maintenance of anesthesia. Agents can be given by continuous inhalational anesthesia or by continuous or bolus IV infusion.

During maintenance, the child may breathe spontaneously through an anesthetic mask or endotracheal tube or may be mechanically ventilated. All general anesthetic agents decrease end-expiratory lung volume, which is generally lower than functional residual capacity, with increases in pulmonary closing capacity and intrapulmonary shunt. Hypoxia would occur without supplemental oxygenation. These effects are compounded by respiratory depressant effects and the depressed CO2 response curve. Therefore, it is generally considered that use of anesthetics for >1 hr requires endotracheal intubation and positive pressure ventilation. For long procedures, spontaneous breathing through a mask is possible; in smaller children, in whom the surgical field and the airway may be close together, the need to maintain a patent airway necessitates endotracheal intubation.

Muscle relaxation to facilitate endotracheal intubation was once accomplished with succinylcholine. This agent has a high risk profile, however, and is associated with postoperative pain (muscle spasms); hyperkalemia; elevated intracranial, intraocular, and intragastric pressures; malignant hyperthermia; and myoglobinuria and renal damage. Succinylcholine is now rarely used, except to provide rapid relief of laryngospasm. Intubation of the airway is facilitated with a nondepolarizing, short-acting muscle relaxant. Rocuronium is the drug most commonly used for intubation. For procedures that last >40 min, vecuronium and alcuronium are suitable to induce muscle relaxation for intubation. After intubation of the airway, the decision must be made whether to maintain muscle relaxation to facilitate surgery or to allow the child to resume spontaneous respiration. Prolonged use of a nondepolarizing muscle relaxant is common practice but may contribute to postoperative respiratory compromise if it is not fully reversed with appropriate agents.

Reversal of neuromuscular blockade is standard anesthetic practice. Effects of nondepolarizing muscle relaxants are reversed by increasing the concentration of acetylcholine with neostigmine (acetylcholine esterase inhibitor) and either atropine or glycopyrrolate to prevent the vagal effects. With the virtual abandonment of succinylcholine, only nondepolarizing muscle relaxants are routinely used for intubation. The termination of their action depends on metabolism and elution away from the neuromuscular junction. This process, even for the shortest-acting muscle relaxants (rocuronium), can take several minutes. An intubating dose of rocuronium to rapidly induce paralysis in emergency situations may not spontaneously reverse for ≥20 min (compared with ≈ 3 min for succinylcholine). If the airway cannot be secured, disaster may follow in the child who is unable to breathe spontaneously and in whom blockade cannot be reversed.

Sugammadex can irreversibly trap rocuronium and thus rapidly reverse its effect with few side effects. This unique (but not FDA-approved) compound may improve the safety of neuromuscular blockade, especially in emergency situations.

Thermoregulation is critical during anesthesia. The absence of movement and the inhibition of shivering lead to difficulty in thermogenesis. All the factors of heat loss—convection, radiation, evaporation, and conduction—occur during anesthesia. Humidification and warming of inspired air are required. Additional warming devices are commonly used, such as rewarming blankets (e.g., Bair Hugger, Arizant Inc., Eden Prairie, MN). General anesthetic agents increase the interthreshold range (the minimal temperature change that will lead to sympathetic response, generally 0.3°C). Although temperature sensing may remain normal, an autonomic response to hypothermia is not triggered. Anesthetic agents cause vasoparesis, which further impairs thermoregulation and increases heat loss. In newborns, inhalational anesthetics inhibit nonshivering thermogenesis from brown fat, putting them at higher risk for hypothermia.

Fluid Maintenance during Surgery and Anesthesia

Patients who are unconscious and immobile have lost venous pump mechanisms and have peripheral venous pooling. Anesthetic agents cause vasodilation, and anesthetized patients have relative hypovolemia. Intravascular volume expansion is frequently required after the induction of anesthesia to maintain adequate perfusion, tissue oxygenation, urine output, and blood pressure. Volume expansion is most commonly provided by isotonic salt-containing solutions (normal saline, lactated Ringer). Autonomic responses may be increased as part of the surgical stress response, with vasoconstriction and intravascular volume contraction due to diuresis, intravascular volume loss from hemorrhage, evaporation (insensible loss, increased during surgery) and third space (interstitial space) fluid losses due to the inflammatory response. Abnormalities in the distribution of renal blood flow and secretion of antidiuretic hormone further complicate the regulation of intravascular volume.

The concern about hypoglycemia due to preoperative fasting led to the recommendation that infants and small children receive isotonic solutions with 5% glucose. The occurrence of hyperglycemia and potential neurologic injury during cardiopulmonary bypass, or during neurosurgery and other situations in which central nervous system (CNS) injury can occur, however, along with the recognition that hypoglycemia is rare in non-neonates, has called into question the routine use of glucose-containing solutions. In neonates, glucose monitoring during and after anesthesia is indicated. In older children with normal nutritional status, isotonic salt solutions without additional glucose are adequate. In children who are receiving parenteral alimentation with a solution containing a high glucose concentration (>10%), continuation of the glucose concentration should be ensured to avoid rebound hypoglycemia, which would occur if the high-glucose solution was stopped.

Intraoperative fluid maintenance includes: (1) current maintenance fluids and replacement of usual deficits during the NPO period; (2) replacement of third space losses; and (3) replacement of extraordinary losses (hemorrhage). Infants should receive glucose-containing isotonic fluids, such as 5% dextrose in water (D5W) with 0.25 normal saline or isotonic crystalloid solutions. A guideline for determining fluid deficits and maintenance requirements in the operating room is shown in Table 70-6. Fluid deficits should be replaced over the first 2 or 3 hr of intraoperative management. Deficits are generally calculated as the number of hours of NPO status multiplied by the hourly maintenance rate for the child. Half of this deficit is replaced during the 1st hr and half during each of the subsequent 2 hr. If hypotension or tachycardia occurs or persists in the early stages of anesthesia, more rapid replacement of the fluid deficit is indicated. The deficit is replaced with isotonic crystalloid solutions.

Table 70-6 INTRAOPERATIVE PEDIATRIC FLUID REPLACEMENT

4 mL/kg/hr 1-10 kg
2 mL/kg/hr 10-20 kg
1 mL/kg/hr per kg >20 kg
Example: a 22-kg child requires: (4 × 10) + (2 × 10) + (1 × 2) = 62 mL/hr

Third space losses are replaced with isotonic salt solutions. For large operations, such as abdominal or thoracic procedures, during which there may be a large amount of evaporative loss as well as a significant amount of third space loss, 8-10 mL/kg per hr of surgery is generally given as IV fluid replacement. For smaller operations, such as herniorrhaphy, pyloromyotomy, and minor procedures, fluid replacement at 3-5 mL/kg/hr is indicated for third space losses. Even when surgery involves the extremities and third space losses are minor, it is wise to give an additional 1-2 mL/kg/hr to replace them.

A crystalloid solution is indicated for blood loss, at 3 mL per mL of blood lost. This formula could be reduced somewhat if blood is replaced on an mL-per-mL basis with packed red blood cells or whole blood equivalent. The use of albumin or other suitable colloid, such as fresh frozen plasma in neonatal surgery, also decreases the amount of crystalloid replacement needed for blood loss. During maintenance anesthesia, if large-volume transfusions are required, warming the blood and crystalloid solutions avoids hypothermia. With major surgery and the resultant SIRS, capillary integrity is lost and third space losses are common. Failure to replace this third space loss and restore intravascular volume leads to hypotension, shock, acidemia, and renal failure, and further stimulates the SIRS.

Recovery from Anesthesia

Recovery from anesthesia includes emergence and postoperative recovery from surgery and anesthetics. Emergence describes the time and the physiologic response to decreasing depth of anesthesia during return to consciousness. During emergence, patients experience decreased anesthetic effect, increased stress responses, physiologic and psychologic responses to painful stimuli, excitement, and anxiety. Conscious realization of pain may lead to physiologic responses during emergence. Normal physiologic functions, such as spontaneous ventilation, resume and hemodynamic function improves. After routine elective procedures, the child should be fully conscious before leaving the operating room, with intact airway reflexes, the ability to follow simple commands, the effects of muscle relaxants reversed, and airway patency maintained. If the child is going to the ICU, or if for surgical reasons the decision is made to leave the child intubated, analgesia and sedation should be maintained, along with mechanical ventilation, in the postoperative period. Ideally, emergence should be as brief as possible, with maintenance of analgesia and anxiolysis and restoration of cardiorespiratory function. Inhalational anesthetic agents leave the system rapidly during ventilation, and muscle relaxants can be reversed; however, the effects of opioids, benzodiazepines, and IV hypnotic agents may be prolonged.

During emergence, the decision must be made whether to reverse the effects of muscle relaxants. The effects of long-acting, nondepolarizing muscle relaxants (vecuronium and pancuronium) are invariably reversed. If the child appears to be weak or to have respiratory depression in the postoperative phase, prolonged neuromuscular blockade should be considered.

Postanesthesia Care Unit

In the postanesthesia care unit (PACU), the child is observed until there is adequate recovery from anesthesia and sedation. Parents should be permitted to comfort their children in the PACU. Achievement of spontaneous breathing, adequate arterial saturation (>95%), and hemodynamic stability are key recovery endpoints. The child should be arousable, responsive, and oriented before discharge from the PACU. The amount of time spent in the PACU depends on whether the child is being discharged to an inpatient nursing unit, to an ICU, to a postrecovery area, or directly home. Discharge from the PACU depends on the child’s overall functional status—not merely the physiologic endpoints, but also the behavioral endpoints as well as the adequate provision of analgesia and control of postoperative nausea and vomiting. There are several scoring systems (Table 70-7) for determining whether a child is ready to be discharged from the PACU.

Table 70-7 RECOVERY SCORES

ALDRETE RECOVERY SCORE >9 REQUIRED FOR DISCHARGE
ACTIVITY—VOLUNTARILY OR ON COMMAND
Moves 4 extremities 2
Moves 2 extremities 1
No motion 0
BREATHING
Deep breath, cough, cry 2
Dyspnea or shallow breathing 1
Apnea 0
BLOOD PRESSURE
Within 20% of preanesthetic value 2
Within 20–50% of preanesthetic value 1
>50% outside preanesthetic value 0
COLOR
Pink 2
Pale, blotchy, dusky 1
Cyanotic 0
CONSCIOUSNESS
Fully aware, responds 2
Arouses to stimulus 1
Unresponsive 0
STEWARD RECOVERY SCORE 6 REQUIRED FOR DISCHARGE
ACTIVITY
Moves limbs purposefully 2
Nonpurposeful movement 1
Still 0
CONSCIOUSNESS
Awake 2
Responsive 1
Unresponsive 0
AIRWAY
Coughing on command or crying 2
Maintaining patent airway 1
Requires airway maintenance 0

Complications in the PACU

Respiratory Depression

Prolonged emergence from anesthesia and respiratory depression can be caused by opioids or inadequate antagonism of neuromuscular blocking agents. Pain can cause significant hypoventilation, especially after thoracic or abdominal surgery. Delayed emergence from anesthesia can occur as a result of retention of inhaled anesthetic agents worsened by hypoventilation. Hypothermia, especially in neonates, delays metabolism and excretion of anesthetics and also aggravates neuromuscular blockade. If respiratory depression is profound, then maintenance of the airway may require an oral airway. If the depression is severe, endotracheal intubation and mechanical ventilation are indicated.

Only in rare cases, in which opioid suppression is suspected, is reversal of the effects of opioid with naloxone indicated. Opioid reversal with naloxone reverses not only the respiratory depression but also the analgesia. A somnolent child with respiratory depression may become excited, agitated in severe pain, uncontrollable, and/or hypertensive after naloxone. Opioid reversal necessitates bedside attention by the physician to monitor the child’s behavioral, hemodynamic, and respiratory status. Naloxone is shorter-acting than most opioid analgesics.

Atelectasis is another respiratory complication occurring in the first 48 hr after anesthesia. Although atelectasis suggests an inhaled foreign body, it is most likely caused by secretions and decreased respiratory effort secondary to pain. Microatelectasis may lead to postoperative infections. Aspiration pneumonia is another postoperative complication.

Postoperative stridor occurs in up to 2% of all pediatric patients. The use of uncuffed, atraumatic, nonirritant endotracheal tubes has decreased the incidence of airway trauma. The use of appropriately sized endotracheal tubes and assurance of an air leak <30 cm H2O pressure further decreases the risk of airway trauma. A history of stridor increases the likelihood of postoperative complications. Stridor may be severe enough after extubation to require re-intubation. Retractions and respiratory distress in the postoperative period should suggest this complication, and stridor or wheezing should confirm the diagnosis. Racemic epinephrine aerosols are effective therapy; their use requires prolonged observation because of the potential for recurrence of the airway obstruction. Stridor in infants suggests the need for overnight observation.

Hemodynamic instability is much less common in the PACU. Volume expansion may be required to maintain adequate blood pressure, peripheral perfusion, and urine output. Requirement for excessive volume replacement (>30 mL/kg) to maintain blood pressure, perfusion, and urine output in the postoperative period is an indication of shock and occult bleeding, and it necessitates surgical consultation.

Emergence delirium is noted in <3% of children and is more common in those 3-9 yr old. In the immediate hour after surgery, children may become extremely restless, combative, and disoriented, and may be screaming, crying, or poorly communicative. These children pose a danger to themselves. This phenomenon is more common when barbiturates are used as part of premedication or induction and inhalational anesthetics or ketamine forms part of the maintenance anesthetic. Although disorientation is common in the postanesthetic stage, erratic, delirious behavior requires attention, with gentle restraint, a quiet environment, and comforting. Potential postoperative complications, such as hypoglycemia and hypoxemia, should be ruled out. Occasionally, it is necessary to sedate the child with benzodiazepines, although these agents prolong postanesthesia recovery time and when they wear off, emergence delirium may occur.

Postoperative Nausea and Vomiting

After general anesthesia, 40-50% of children may experience nausea and vomiting. More than 80% of all high-risk children receiving inhalational anesthesia experience postoperative nausea and vomiting (PONV). It may occur in the immediate postoperative period, within the first 1-2 hr, or several hours after surgery and anesthesia. The etiology may be related to the stress and trauma of surgery combined with the emetic effects of anesthetic agents. Pain is an important cause of nausea and vomiting. Opioid analgesics also induce nausea and vomiting. Preoperative fasting does not decrease the incidence of nausea and vomiting. Indeed, hydration and glucose supplementation appear to be important factors in decreasing PONV. The use of analgesic agents other than opioids (acetaminophen, ketorolac) and regional or local anesthesia is associated with decreased PONV.

This complication prolongs recovery room times, requires significant nursing attention, and increases the use of potent antiemetic agents (ondansetron, other serotonin antagonists). Ondansetron is very efficacious as a prophylactic and in the treatment of PONV. Ondansetron and other serotonin antagonists are recommended for high-risk patients (strabismus surgery) or for actual treatment of PONV. They are contraindicated in children taking serotonin reuptake inhibitors for migraine headaches. Metoclopramide is useful prophylactically. Droperidol (which now has an FDA-required black box label warning) must be used with caution because of the rare occurrence of prolonged QT interval and ventricular arrhythmias associated with its use.

Thermoregulation and Malignant Hyperthermia

For patients in the PACU, thermoregulation remains abnormal for several hours. Shivering is common in the postoperative state, and a feeling of extreme cold is common. Warm blankets are very comforting and seem to decrease shivering. Hypothermia, especially in neonates, leads to hypotension, bradycardia, acidosis, apnea, and prolongation of the effect of opioids and neuromuscular blocking agents. Although hypothermia has deleterious effects, rewarming must be done cautiously to avoid burning and cutaneous hyperthermia. Hyperthermia, with temperatures in excess of 39°C, is of concern in the postoperative period. If it occurs within hours of the use of an inhalational anesthetic, especially if succinylcholine was used, malignant hyperthermia must be suspected.

Malignant hyperthermia is an acute hypermetabolic syndrome that is triggered by inhalational anesthetic agents and succinylcholine. It resembles neuroleptic malignant syndrome. The onset of malignant hyperthermia may be acute, and its course may be fulminant and rapidly fatal. This condition, albeit rare (approximately 1/60,000 pediatric patients given anesthesia) is a constant concern. The disease is familial, and a family history of death or a febrile reaction during anesthesia should alert the anesthesiologist to its potential. Its clinical course is characterized by rapid onset of fever, acidosis, hypercarbia, and increased expired CO2. High fever (38.5-46.0°C, rising 1°C every 5 min), muscle rigidity, metabolic acidosis, and hemodynamic collapse can occur. Death ensues from shock and cardiac dysrhythmias with ventricular fibrillation that is unresponsive to treatment. The mortality rate for malignant hyperthermia was once >70%. Aggressive therapy, including discontinuation of all inhalational anesthetic administration, correction of the metabolic acidosis, and treatment with the muscle relaxant sodium dantrolene, has reduced the mortality rate to <5%. Dantrolene and a kit containing supplies necessary to treat malignant hyperthermia should be present at every site where pediatric anesthesia is provided.

Malignant hyperthermia is probably genetically heterogeneous, with >10 genes contributing to susceptibility. Genetic mutations in the ryanodine receptor (the calcium channel of the sarcoplasmic reticulum) have been reported in 20-40% of humans with malignant hyperthermia. Certain myopathies are associated with the risk of malignant hyperthermia; these include Duchenne muscular dystrophy, Noonan phenotype, and, in children with a history of ptosis, squint, scoliosis, and muscle cramping. It is wise to avoid the use of succinylcholine in children with myopathies.

Malignant hyperthermia appears to occur from a massive triggering of excitation contraction coupling, sarcolemmal calcium release, and propagation of contraction by a complex biochemical process. The prolonged ischemic contraction leads to myolysis, with release of myoglobin, very high serum creatine phosphokinase (CPK) levels, and renal failure secondary to myoglobinuria. Malignant hyperthermia generally occurs within the 1st 2 hr of anesthesia but rarely can occur up to 24 hr later.

Certain phenomena are clues to the risk of malignant hyperthermia. The occurrence of masseter spasm during induction, with rigid clenching of the masseter muscles and an inability to open the mouth, may presage full-blown disease. Acute myoglobinuria associated with a malignant hyperthermia–triggering agent is another clue. The child may not be hypermetabolic or febrile, but may have dark urine and high serum CPK levels, with the risk of myoglobin-induced renal tubular damage. The finding of dark urine after administration of an anesthetic requires investigation for malignant hyperthermia. An elevated CPK value and heme-positive urine in the absence of red blood cells in the urine indicate a need for renal protection with mannitol and alkaline diuresis.

Rapid therapy is essential. All known triggering agents must be stopped. Intravenous administration of dantrolene sodium (2.5 mg/kg IV as an initial dose) is begun as soon as possible. The need for repeated doses is indicated by the persistence of muscle rigidity, acidosis, and tachycardia, up to a maximum dose of 10 mg/kg. Once the symptoms are controlled, the patient should be observed for at least 24 hr after the laboratory values have returned to normal, because relapse can occur.

Prevention of malignant hyperthermia in susceptible patients requires the avoidance of triggering agents, which include inhalational anesthetics. Most anesthesiology departments are capable of delivering general anesthetics using anesthesia machines from which all traces of anesthetic vapors have been removed. Intravenous anesthesia and a nitrous-opioid technique are safe. Dantrolene prophylaxis is not recommended because the disease is rapidly treatable and because the drug causes respiratory depression and muscle weakness. For a child in whom malignant hyperthermia is suspected, the malignant hyperthermia hotline, 1-800-MHHYPER, should be used to notify the Malignant Hyperthermia Association of the United States (MHAUS). The MHAUS registers susceptible patients and provides diagnostic and therapeutic information. Preanesthesia susceptibility testing includes genetic analysis of the ryanodine receptor gene, muscle biopsies, in vitro contraction studies, and, possibly, measurement of muscle CO2 production in response to intramuscular caffeine.

Preanesthetic Evaluation

Most previously healthy children require minimal preoperative assessment. The American Society of Anesthesiologists (ASA) classification system for anesthetic care is the ASA Physical Status (PS) classification (Table 70-8).

For ASA PS-1 patients, a brief history, notation of medical allergies, and a physical examination focusing on the airway, lungs, and cardiac function are sufficient. For all children who are being assessed for anesthesia risk, a family history should be obtained, for reactions to anesthetics, for drug allergies, and for sudden intraoperative death or hyperthermia after surgery, which may indicate a risk of malignant hyperthermia. In children who have previously had an anesthetic, questions should be asked regarding intraoperative anesthetic complications. The history should focus on determining whether the child is at risk for anesthetic or surgical stress as well as cardiorespiratory disease and airway compromise.

Recent URIs should be noted. A URI is an upper respiratory illness associated with fever, mucopurulent green or yellow nasal discharge, productive cough, injected sclerae, and increased mucous secretions. Clear rhinorrhea is generally not a concern. URIs can increase airway reactivity for up to 6 wk in both normal children and children with a history of reactive airway disease. URIs can also increase the risk of laryngospasm and bronchospasm, reduce mucociliary clearance, and raise the risk of intraoperative atelectasis and hypoxemia. It is generally recommended to avoid general anesthesia for elective procedures for 4-6 wk after a URI. In patients with chronic sinusitis and nasal polyps, infection should be thoroughly treated before elective anesthesia.

Acute, fatal bronchospasm can occur during induction of anesthesia and endotracheal intubation for routine, minor surgery in children with asthma. Those children at particular risk for anesthetic complications with asthma are those who have been (1) admitted to the hospital within the previous year for their asthma, (2) seen in an emergency department in the last 6 mo, (3) admitted to an ICU, or (4) treated with parenteral systemic steroids. The child should be free of wheezing for at least several days before surgery, even if this necessitates an increase in β-agonist dosage and the addition of steroids. Preoperative steroids are indicated for all children with asthma who are receiving asthma therapy or have received such therapy within the last year. Prednisone, 1mg/kg given 24 and 12 hr before surgery, significantly decreases airway reactivity perioperatively. Active wheezing is an indication for canceling elective surgery. If wheezing cannot be controlled on an outpatient basis with β-agonists, steroids, and other asthma therapy, then hospital admission of the child for more aggressive therapy before surgery is indicated.

Bronchopulmonary dysplasia also poses significant intraoperative risks. The same applies to cystic fibrosis and other chronic lung diseases. Every effort should be made to ensure that children with such disorders achieve the best possible respiratory status before surgery. Infections should be treated and reactive airways optimally treated without evidence of wheezing.

Mediastinal Masses

Children with anterior mediastinal masses, such as lymphomas and primary mediastinal tumors, are at serious risk for airway compromise, cardiac tamponade, and vascular obstruction. Induction of general anesthesia and even mild sedation can lead rapidly to total loss of the airway, with inability to ventilate the child and cardiovascular collapse. These patients often present in a semi-emergency fashion, with the need for both a tissue diagnosis of the mass before treatment is initiated and a surgically placed central venous line.

Significant compression of vital structures can occur with seemingly mild symptoms. Tachypnea, orthopnea, wheezing, and sleep disturbances or avoidance of prone or supine positions are significant indications of serious risk. Pericardial tamponade or superior vena cava syndromes are more concerning findings. A CT scan showing >50% compression of the airway at the carina is an indication to prohibit general anesthesia and provide only mild sedation. Echocardiographic or CT evidence of pericardial tamponade, right ventricular compression, or compression of the pulmonary artery suggests severe risk. Biopsy with the child under local anesthesia may be indicated. If anesthesia is required, cardiopulmonary bypass should be considered, in case it becomes impossible to ventilate the child during surgery. In high-risk children, consideration should be given to initiating treatment with steroids, radiation therapy, and chemotherapy before obtaining a tissue diagnosis.

Down Syndrome

Children with Down syndrome are occasionally behaviorally difficult and are especially fearful of medical caregivers (Chapter 76). Their cardiac anomalies, macroglossia, and upper airway obstruction can be challenging. Children with Down syndrome have atlantoaxial instability due to odontoid hypoplasia and joint laxity. In younger children, extension of the neck, routinely used to maintain and intubate the airway, may lead to cervical dislocation and spinal cord trauma. Some anesthesiologists recommend extension and flexion lateral neck films to detect instability before anesthesia. In children with Down syndrome, it is wise to exercise caution in stabilizing the cervical spine and also to avoid cervical flexion and extension.

Cardiovascular System

Because of the depressant effects of anesthetics and the increased metabolic demands of surgery, any compromise of myocardial function should be clearly delineated preoperatively. A preoperative ECG, an echocardiogram, and a cardiology consultation are indicated for children with a history of heart disease. An intracardiac shunt will affect oxygenation status intraoperatively. Because of the significant effect on the oxygen supply-and-demand relationship caused by general anesthesia and surgical stress, obstructive lesions, such as a valvular stenosis, must also be clearly defined. A history of cardiac dysrhythmias should be clearly understood, because inhalational anesthetics are dysrhythmogenic.

In neonates, ductus arteriosus, myocardial compromise, pulmonary edema, or congenital heart disease can significantly complicate oxygen delivery during anesthesia. Accurate diagnosis of cardiac murmurs in neonates is essential. Any preoperative cardiovascular compromise will be worsened intraoperatively and can catastrophically complicate the perioperative course.

Anemia should be diagnosed and corrected preoperatively if possible. A hematocrit value >30% is generally acceptable for routine elective anesthesia. If there are reasons to expect significant blood loss or prolonged convalescence, anemia should be corrected preoperatively. In the emergency setting, transfusion may be required. Although lower hematocrit values can be tolerated in unstressed children, the significant threat to oxygen delivery posed by anesthesia and surgery, especially if blood loss is expected, requires maintenance of an adequate hemoglobin concentration perioperatively.

Evidence of coagulopathy should be sought. Easy bruising, the use of aspirin, and familial bleeding disorders should be discussed. Intraoperative hemorrhagic bleeding can be difficult to control; massive perioperative blood transfusions have significant risk of morbidity and mortality. Preoperative correction of coagulopathic disorders is indicated. In neonates, assurance of vitamin K prophylaxis and adequate coagulation status is critical before any significant surgery. In neonates and critically ill children, adequacy of platelet count and, where indicated, coagulation factors, prothrombin time, and partial thromboplastin time should be assured.

Neurobehavioral Considerations

Seizures, significant neurologic impairment, altered level of consciousness, respiratory airway compromise secondary to neurologic disease, and neuromuscular disease should be sought and evaluated. Anticonvulsant drug metabolism is often altered perioperatively, and this change may affect anticonvulsant drug levels. Anticonvulsants may also complicate anesthetic management. Maintenance of appropriate anticonvulsant therapy postoperatively is important to avoid new seizures. Cerebrospinal fluid secretion is increased during surgery and general anesthesia. This fact is significant in patients in whom elevated intracranial pressure is suspected and in children with ventriculoperitoneal shunts. In infants or older children with ventriculoperitoneal shunts, shunt patency and function should be assured before surgery.

Illness and the need for surgery or painful medical procedures are psychologically traumatic events for children and their families. Children are also remarkably adept at sensing stressful signals from their parents and caregivers. Many children who require anesthesia may have significant levels of fear and anxiety. Most children undergoing surgery have new-onset negative behavioral changes in the postoperative period, such as maladaptive behavioral responses that include generalized anxiety, enuresis, enhanced separation anxiety, temper tantrums, nighttime crying, and fear of strangers, doctors, and hospitals. Approximately 20% show these negative behavioral adaptations for 6 mo after surgery. Sleep quality is also altered postoperatively, resulting in further behavioral compromise.

The risk factors for postoperative behavioral changes include preoperative or induction anxiety and behaviors indicating extreme stress, as well as emergence excitation. The type of surgery may be important, with tonsillectomy and genitourinary surgery having a high incidence of postoperative behavioral changes, whereas simple procedures (tympanostomy tubes) seem to be associated with fewer changes. Another risk factor is recurrent procedures, such as anesthesia for laser surgery, strabismus surgery, or repeated eye examinations, which lead to difficult behavioral changes and have a significant effect on family dynamics.

Preoperative psychologic preparation programs decrease the incidence of postoperative behavioral changes, which last for up to 1 mo. PPI does not improve postoperative behavior. Oral midazolam (0.5 mg/kg) may decrease negative behavioral changes after surgery. Midazolam has the benefit of providing not only rapid-onset anxiolysis in 10-20 min but also very effective and rapid (10 min) amnesia.

Preoperative Preparation

The child should be in the best possible nutritional state, and nutritional supplementation, even hyperalimentation in chronically ill children, may be worthwhile.

Preoperative Fasting

Aspiration of gastric contents is a perioperative disaster and, if superimposed on lung disease, may be rapidly fatal. Aspiration may lead to laryngospasm and bronchospasm, with hypoxemia and hypoxic ischemic encephalopathy. It may also produce intraoperative atelectasis and postoperative pneumonia. It is vital to ensure that the stomach is as empty as possible before the induction of anesthesia. Acid aspiration is less likely with an empty stomach. Preoperative fasting (NPO status) guidelines are noted in Table 70-10.

Clear, sweet liquids (Pedialyte, D5W) facilitate gastric emptying, help avoid hypoglycemia, and can be given up to 2 hr before anesthesia in any child. For older infants and children, a fasting period of 4 hr for liquids provides optimal safety and minimal discomfort. Solids must be avoided for at least 8 hr before surgery. Because surgery is frequently scheduled in the morning, and for ease and clarity of understanding, the general guideline is no consumption of solids after midnight. Many conditions delay gastric emptying, and prolonged periods of fasting may be required in the presence of stress, anxiety, illness, trauma, gross obesity, or biliary atresia, or in children with delayed gastric emptying for other reasons.

Table 70-10 GUIDELINES FOR PREOPERATIVE FASTING (“2-4-6-8 RULE”)*

TIME BEFORE SURGERY (hr) ORAL INTAKE
2 Clear, sweet liquids
4 Breast milk
6 Infant formula, fruit juices, gelatin
8 Solid food

* These are general guidelines and may differ among hospitals.

The Full Stomach

Because of the serious complications of aspiration of gastric contents, it is desirable to secure the airway as rapidly as possible after obtundation in patients at risk for having a full stomach. Gastric emptying may be delayed for up to 96 hr after an acute episode of trauma or surgical illness. Under these circumstances, induction of general anesthesia and endotracheal intubation are performed in a rapid sequence (rapid sequence induction) (Chapter 62).

The risks of rapid sequence induction include the possibility that if the airway cannot be intubated, the child is paralyzed without a protected airway and ventilation may be hazardous or impossible. Rapid sequence induction should be performed by those who can definitely achieve endotracheal intubation quickly. It should be avoided in patients with a history of failed oral endotracheal intubation or with any of many syndromes (micrognathia) associated with difficult intubation. Under these circumstances, bronchoscopic awake intubation may be indicated.

Before rapid sequence anesthesia induction, the child should be preoxygenated by breathing 100% oxygen for 2 min to give an extra margin of safety if intubation is difficult. The child should not receive assisted ventilation either before or after the administration of drugs because this may lead to increased gastric air and actually increase the likelihood of vomiting, regurgitation, and aspiration.

One common regimen for rapid sequence induction includes the administration of 1.5-3 mg/kg of propofol concurrently with either 0.9-1.2 mg/kg of rocuronium or 1.5 mg/kg of vecuronium. Immediately after the administration of sedation and muscle relaxants, the Sellick maneuver (cricoid pressure) should be performed by applying firm pressure in a posterior direction against the cricoid cartilage. This displaces the cricoid cartilage into the esophagus, forming an artificial sphincter to prevent reflux of the gastroesophageal contents. Cricoid pressure should be maintained until correct placement of the endotracheal tube is verified by direct visualization, fogging of the tube, and, in all circumstances, positive end-tidal CO2.

Postoperative Pain Management

Continuation of analgesia and anxiolysis should follow surgery or painful procedures (Chapter 71). Complete freedom from pain is not possible. Preoperative education about the surgery and a pain management plan, development of skills designed to decrease anticipatory anxiety, and active participation in treatment planning can be helpful for some children and families. Adjunctive therapy, such as visual reality, hypnosis, pet therapy, and play therapy, also can decrease the need for potent analgesics postoperatively.

The combination of opioid and nonopioid analgesic agents and an understanding of the benefits and risks provide the foundation of pain management. A judicious combination of nonsteroidal anti-inflammatory drugs, cyclo-oxygenase-2 (COX-2) inhibitors, opioids, and regional analgesia has a role in postoperative pain management. Repeated evaluation is as important as the modality of pain management. Continuous and repetitive small doses of analgesia around the clock are more effective at reducing pain than occasional “as needed” (prn) dosing intervals.

Patient-controlled analgesia (PCA), nurse-controlled analgesia, and parent-controlled analgesia are all used postoperatively (Chapter 71). PCA provides continuous pain treatment and self-medication (vs intermittent or prn pain control) as well as control and comfort in an otherwise personally uncontrolled circumstance. PCA provides both a background low-dose infusion rate of a continuous opioid and the opportunity to supplement analgesia with bolus doses as needed. The practitioner can determine the continuous infusion rate, the bolus dose, the lockout interval, and the number of boluses per unit time that the patient may receive. PCA relies on the theory that patients cannot or will not overdose themselves because somnolence will decrease repeated self-administration. In young children, the use of the pain button (for pain relief) may be more difficult to ensure; children as young as 5yr have been able to use PCA successfully. In older children and adolescents, PCA should be a standard modality of postoperative pain management.

Regional Anesthesia

Regional anesthesia is the use of anesthetics to block the conduction of afferent neural impulses to the CNS. These can be local analgesic techniques, peripheral nerve blocks, nerve plexus blocks, or epidural and subarachnoid (spinal) nerve blocks. They may be administered either through a single injection (single shot) or through continuous infusion, as is common with epidural and occasionally subarachnoid blocks. They may be used for intraoperative anesthesia and postoperative analgesia, and they have the potential to decrease intraoperative analgesia and anesthetic use as well as to provide postoperative pain management. Increased use of regional indwelling catheters to deliver continuous analgesia has shortened recovery times and hospital stays in children.

Analgesia at the site of need, without central cardiorespiratory depressant effects, can be valuable. Local anesthesia, with injection of lidocaine or bupivacaine into the affected area, can provide procedural analgesia that lasts for several hours. Infiltration of the wound site and the edges of an incision decreases postoperative pain in the initial hours after surgery. This can be performed by the surgeon at the conclusion of surgery and may supplement postoperative analgesia.

Epidural analgesia is common in pediatric practice. The epidural space lies between the dura and the pia and arachnoid membranes, an area through which all nerve roots pass. Bathing these nerve roots in local anesthetics inhibits conduction of pain impulses centrally. A single dose of epidural anesthetic may provide hours of pain relief, and a continuous infusion may provide effective pain relief for hours to days. The epidural injection of opioids can provide analgesia for 12-24 hr and is a potential supplement to postoperative analgesia.

A lumbar epidural injection is placed in the lumbar area to provide analgesia for labor and for surgery below the thorax. Caudal epidural analgesia is placed through the sacral hiatus, inferior to the distal end of the spinal cord. This is the site most commonly used for regional anesthesia and analgesia in children and is efficacious for the provision of pelvic and lower limb anesthesia as well as beneficial in orthopedic and urologic surgery. A continuous infusion of bupivacaine is the most common means of providing postoperative epidural pain relief; it may be mixed with an opioid (fentanyl or preservative-free morphine). It is also possible to provide epidural PCA with a continuous infusion pump and the ability of the patient to self-medicate with bolus prn dosing. Epidural analgesia can also provide pain relief in patients with chronic pain or pain caused by advanced malignant conditions.

The most serious complications of neuraxial anesthesia include cephalad spread of blockade with respiratory depression, paralysis of respiratory muscles, and, in extreme cases, brainstem analgesia and depression. The most common complications of neuraxial analgesia include mild discomfort; a paresthesia-like feeling of numbness and tingling; pruritus, which, if opioids are used, can be quite distressing; and occasional nausea and vomiting. Infection and epidural hematoma are extremely rare. Neuraxial opioids, especially when administered intrathecally, can cause respiratory depression; their use requires postoperative monitoring. The use of neuraxial opioids often requires treatment with antipruritic as well as antiemetic drugs.

70.1 Sedation and Procedural Pain

The same drugs that induce general anesthesia are often used to provide sedation (see Table 70-5 on the Nelson Textbook of Pediatrics website at image www.expertconsult.com). Sedation care requires a presedation evaluation, intraprocedural monitoring and postsedation recovery, analogous to the provision of anesthesia. Sedation is on the continuum between wakefulness and general anesthesia (see Table 70-4 on the Nelson Textbook of Pediatrics website at image www.expertconsult.com). The term conscious sedation refers to a condition in which a patient is sleepy, comfortable, and cooperative but maintains airway-protective and ventilatory reflexes. Unfortunately, for most children, this level of sedation provides little or no analgesia, and both psychologic and physiologic responses to painful stimuli persist. Sedation that is sufficient to obtund painful responses is most likely deep sedation. Deep sedation is a state of unarousability to voice and is accompanied by suppression of reflex responses. Management of sedated children requires vigilance and knowledge to ensure their safety and is governed by the same guidelines as anesthesia care (see Table 70-11 on the Nelson Textbook of Pediatrics website at image www.expertconsult.com). A dose of sedative medication that causes minimal sedation in one subject may produce complete unconsciousness and apnea in another. Careful attention to guidelines for appropriate monitoring and management of sedation in children is imperative. For threatening and nonpainful procedures, anxiolysis or light sedation is frequently sufficient. For painful procedures (e.g., bone marrow aspiration, insertion of percutaneous IV catheter lines, lumbar punctures), the combination of sedation with analgesia that is required in children produces deep sedation.

Many specialists provide sedation and anesthesia care for children. The use of anesthetic agents is not limited to anesthesiologists, but a hospital’s Department of Anesthesiology provides expertise in developing and managing systems of anesthesia care, including sedation. With the widespread use of the deceptively safe general anesthetic agent propofol to provide sedation, hospitals, pediatricians, and other care providers must ensure that credentialing, oversight, quality assurance, and protocols for administration of anesthetic agents provide safe care. Involvement of anesthesiologists in organizing services, training other practitioners, overseeing safety, systems, and quality, and remaining involved in the delivery of such care is sound practice. The elements of a safe system to provide procedural sedation for children are as follows:

Sedation with chloral hydrate, pentobarbital, or benzodiazepines is often adequate for nonpainful procedures. Nevertheless, there can be a high failure rate for as well as complications of this method, such as prolonged sedation (hours to overnight), ataxia, nausea and vomiting, desaturation, and the occasional need for rapid intervention. The temptation to add opioids and deepen sedation increases the risk of complications. The use of dexmedetomidine for procedural sedation is safe; recovery time can be prolonged, and success can be variable. The quickest way to ensure safely reversible sedation is with potent anesthetic agents. The ultra–short-acting anesthetics (propofol, methohexital, remifentanil) provide effective procedural sedation, but their use carries a higher likelihood of inadvertent oversedation and induction of general anesthesia. These anesthetics offer efficient and rapidly reversible procedural sedation. However, their use requires the presence of an anesthesiologist and/or specially trained, experienced, and qualified physicians.

70.2 Anesthetic Neurotoxicity

There is compelling experimental evidence that anesthesia-induced neurodegeneration with developmental impairment occurs in neonatal animals. Pediatric anesthesiologists have become deeply concerned by the demonstration of anesthetic-induced apoptotic neuronal cell death, CNS neurodegenerative changes, and their effects on the developing brain. These studies demonstrate both histopathologic changes and developmental defects from both inhalational and IV anesthetics, including isoflurane, ketamine, benzodiazepines, and propofol given to newborn animals. Combinations of drugs may cause more injury. Existing nonclinical data implicate both NMDA and GABA pathways in apoptosis and cell death in neonates.

The studies reporting these results were performed in animals (largely rodents), and great controversy exists concerning dose, duration of treatment, species differences, and experimental design. Although there is cause for concern and further study, alternatives to general anesthesia for many procedures in infants do not exist. Perhaps regional anesthetic techniques and narcotic-based anesthetics will be increasingly used. Interestingly, dexmedetomidine appears to block the neurotoxic effects of other anesthetics. There is insufficient current data for suggesting the safety of one anesthetic approach over another. The potential for this neurotoxicity must be balanced against the necessity of providing adequate anesthesia for neonates.

Bibliography

Akporehwe NA, Wilkinson PR, Quibell R, et al. Ketamine: a misunderstood analgesic? BMJ. 2006;332:1466.

Brandom BW. The genetics of malignant hyperthermia. Anesthesiol Clin North Am. 2005;23:615-619.

Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010;363:2638-2650.

Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med. 2003;348:2110-2124.

Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg. 2006;102:1884-1898.

Gozal D, Gozal Y. Pediatric sedation/anesthesia outside the operating room. Curr Opin Anesth. 2008;21:494-498.

Hampson-Evans D, Morgan P, Farrar M. Pediatric laryngospasm. Pediatr Anesth. 2008;18:303-307.

Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62:690-701.

Malviya S, Voepel-Lewis T, Tait AR, et al. Effect of age and sedative agent on the accuracy of bispectral index in detecting depth of sedation in children. Pediatrics. 2007;120:e461-e470.

Markovitz BP. The drug that would not die (though patients receiving it do). Pediatr Crit Care. 2009;10:418-419.

Maxwell LG, Yaster M. Perioperative management issues in pediatric patients. Anesthesiol Clin North Am. 2000;18:601-632.

Neelakanta G, Chikyarappa A. A review of patients with pulmonary aspiration of gastric contents during anesthesia reported to the Departmental Quality Assurance Committee. J Clin Anesth. 2006;18:102-107.

Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115-131.

Tobias JD. Therapeutic applications of regional anesthesia in paediatric-aged patients. Paediatr Anaesth. 2002;12:272-277.

Walther-Larsen S, Rasmussen LS. The former preterm infant and risk of post-operative apnoea: recommendations for management. Acta Anaesthesiol Scand. 2006;50:888-893.